title: The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study.
authors.forename: M
authors.initials: M
authors.lastname: Afshar
authors.forename: P
authors.initials: P
authors.lastname: Kotol
authors.forename: J
authors.initials: J
authors.lastname: Miller
authors.forename: R
authors.initials: R
authors.lastname: Gallo
authors.forename: T
authors.initials: T
authors.lastname: Hata
mesh_terms: D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects*; D018793:Interleukin-13 / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D003879:Dermatologic Agents; D018793:Interleukin-13; D012333:RNA, Messenger; C117268:pimecrolimus; D016559:Tacrolimus